[{"data":1,"prerenderedAt":378},["ShallowReactive",2],{"content-route-/en/symptoms-conditions/vaginal-yeast-infection":3},{"state":4,"owner":4,"route":5,"locale":6,"template":7,"content":19,"projection":167,"alternates":369},"target","/en/symptoms-conditions/vaginal-yeast-infection","en-US",{"kind":8,"family":9,"sectionKeys":10},"condition","guidance",[11,12,13,14,15,16,17,18],"definition","stages","diagnosis-states","differentials","options","expected-course","recurrence","evidence",{"kind":8,"title":20,"description":21,"firstPublished":22,"evidenceAsOf":22,"lastUpdated":22,"changeNote":23,"firstLayer":24,"stageRoutes":54,"differentials":57,"relations":71,"body":110},"Vaginal symptoms: what they can mean and what to do next","Start with the symptoms you can observe, see why symptoms alone cannot confirm a vaginal yeast infection, and choose the right next route for a first episode, recurrence, or treatment that did not work.","2026-07-15","Complete initial draft based on the Pathway A orientation and US authority packs.",{"question":25,"answer":26,"keyPoints":27,"confidence":31,"applicability":34,"nextSteps":41},"Do vaginal itching, burning, soreness, pain, or discharge mean a yeast infection?","These symptoms can occur with vulvovaginal candidiasis, but symptoms alone cannot identify yeast as the cause. A first unexplained episode is an unresolved symptom problem; repeated or treatment-persistent symptoms need reassessment rather than another assumption that yeast remains.",[28,29,30],"No single symptom confirms vulvovaginal candidiasis because several infectious and noninfectious conditions overlap.","A Candida result without compatible symptoms and signs does not by itself establish symptomatic infection.","Pregnancy, possible pregnancy, compromised immunity, diabetes, persistence, or early return changes the safest care route.",{"summary":32,"rationale":33},"Strong confidence that symptoms alone cannot identify the cause; the exact cause remains individual and requires appropriate evaluation.","CDC diagnostic guidance and ISSVD recommendations agree that symptom patterns overlap and that history, examination, and appropriate testing determine the cause.",{"appliesTo":35,"excludes":38},[36,37],"Adolescents and adults with current vaginal or vulvar itching, burning, irritation, soreness, pain, odor, or discharge.","People who think the symptoms may be yeast but do not yet have a confirmed cause.",[39,40],"People with an immediate medical emergency, who should use the urgent-help route.","People seeking an individual treatment choice; confirmation, pregnancy, health conditions, medicines, and prior response can change that decision.",[42,46,50],{"label":43,"action":44,"route":45},"Choose your stage","Use the first-time, recurring, or treatment-did-not-work route so the next information matches what has happened.","/en/start-here/symptoms-now",{"label":47,"action":48,"route":49},"Prepare for evaluation","Record timing, symptoms, prior test results, treatments, side effects, and response before a clinician visit.","/en/tools/appointment-planner",{"label":51,"action":52,"route":53},"Check urgent routes","Review the observable reasons to seek urgent or emergency help.","/en/urgent-help",{"firstTime":45,"recurring":55,"treatmentFailed":56},"/en/symptoms-conditions/recurrent-vaginal-yeast-infection","/en/symptoms-conditions/vaginal-yeast-treatment-not-working",[58,62,65,68],{"label":59,"discriminator":60,"route":61},"Bacterial vaginosis","A common alternative cause of vaginal discharge or odor that cannot be separated from yeast by history alone.","/en/symptoms-conditions/vaginal-yeast-infection-lookalikes",{"label":63,"discriminator":64,"route":61},"Trichomoniasis or cervicitis","Infections that can overlap with discharge, irritation, pain, or other vaginal symptoms and need cause-specific evaluation.",{"label":66,"discriminator":67,"route":61},"Mechanical, chemical, or allergic irritation","Symptoms may follow friction or exposure to a product even when no vaginal infection is present.",{"label":69,"discriminator":70,"route":61},"Vulvar, inflammatory, or pain condition","Persistent soreness, burning, skin change, or pain may require assessment for a noninfectious vulvar or inflammatory cause.",[72,76,79,83,86,89,91,94,98,101,104,107],{"group":73,"route":74,"label":75},"parent","/en/symptoms-conditions","Symptoms & conditions",{"group":77,"route":61,"label":78},"differential","What can look like a vaginal yeast infection",{"group":80,"route":81,"label":82},"treatment","/en/treatments-evidence/vaginal-yeast-treatment","Vaginal yeast treatment",{"group":80,"route":84,"label":85},"/en/treatments-evidence/topical-vs-oral-vaginal-yeast-treatment","Topical vs oral vaginal yeast treatment",{"group":87,"route":55,"label":88},"recurrenceFailure","Recurrent vaginal symptoms",{"group":87,"route":56,"label":90},"When vaginal yeast treatment does not work",{"group":18,"route":92,"label":93},"/en/research/evidence/recurrent-vaginal-yeast-symptoms","Evidence map for recurrent vaginal yeast symptoms",{"group":95,"route":96,"label":97},"research","/en/research/rvvc-diagnostic-experiences-2026","Study summary on RVVC diagnostic experiences",{"group":95,"route":99,"label":100},"/en/research/rvvc-quality-of-life-2019","Study summary on RVVC and quality of life",{"group":102,"route":49,"label":103},"tool","Appointment planner",{"group":102,"route":105,"label":106},"/en/tools/treatment-history","Treatment history",{"group":108,"route":53,"label":109},"safety","Urgent help",{"type":111,"value":112,"toc":163},"minimark",[113,121,127,133,139,145,151,157],[114,115,117],"content-section",{"section-key":11,"title":116},"What this page covers",[118,119,120],"p",{},"Vaginal and vulvar symptoms are observable problems, not a confirmed condition. Vulvovaginal candidiasis is one possible cause. Similar itching, burning, soreness, pain, odor, or discharge can come from other infectious or noninfectious causes.",[114,122,124],{"section-key":12,"title":123},"First episode, recurrence, or treatment failure",[118,125,126],{},"A first unexplained episode starts as an unresolved symptom presentation. Repeated episodes need the recurrence route, where episode count and confirmation are kept separate. Symptoms that did not resolve, returned, worsened, or changed after treatment need the treatment-failure route and a reopened differential.",[114,128,130],{"section-key":13,"title":129},"Keep the diagnosis state clear",[118,131,132],{},"A confirmed condition, unresolved symptoms, and symptoms attributed to yeast are different states. A familiar pattern does not confirm the cause, and detecting Candida without compatible symptoms and signs does not establish symptomatic infection.",[114,134,136],{"section-key":14,"title":135},"What else can look similar",[118,137,138],{},"Bacterial vaginosis, trichomoniasis or cervicitis, irritation from friction or products, and vulvar or inflammatory conditions can overlap with presumed yeast symptoms. The differential route explains the useful discriminators without ranking causes for an individual.",[114,140,142],{"section-key":15,"title":141},"Choose the next decision",[118,143,144],{},"Use the treatment route only when vaginal yeast infection has been established. The comparison route supports a topical-versus-oral discussion when both are otherwise appropriate. The appointment planner helps organize the symptom, test, and treatment history without determining the cause.",[114,146,148],{"section-key":16,"title":147},"Expected course",[118,149,150],{},"The expected-course estimate applies to confirmed uncomplicated vulvovaginal candidiasis in the specified population, not to every vaginal symptom presentation. Persistence, partial improvement, early return, worsening, or new symptoms changes the next step to reassessment.",[114,152,154],{"section-key":17,"title":153},"When symptoms keep returning",[118,155,156],{},"Current guidance generally uses three or more symptomatic episodes within one year to orient possible recurrence, while older guidance and studies often use four or more. An episode count does not replace microbiologic confirmation before a recurrent-candidiasis management plan.",[114,158,160],{"section-key":18,"title":159},"Evidence and sources",[118,161,162],{},"The linked evidence map traces the exact claims, populations, outcomes, limitations, and research summaries behind this pathway. The page remains a draft until its planned pathway relations are available for publication.",{"title":164,"searchDepth":165,"depth":165,"links":166},"",2,[],{"sources":168,"claims":203,"safety":322},[169,177,181,188,195],{"sourceId":170,"title":171,"canonicalId":172,"canonicalUrl":173,"publisher":174,"sourceType":175,"publicationDate":176,"lastChecked":22},"cdc-sti-vvc-2021","Sexually Transmitted Infections Treatment Guidelines, 2021: Vulvovaginal Candidiasis","doi:10.15585/mmwr.rr7004a1","https://www.cdc.gov/std/treatment-guidelines/candidiasis.htm","US Centers for Disease Control and Prevention","guideline","2021-07-23",{"sourceId":178,"title":179,"canonicalId":172,"canonicalUrl":180,"publisher":174,"sourceType":175,"publicationDate":176,"lastChecked":22},"cdc-sti-vaginal-discharge-2021","Sexually Transmitted Infections Treatment Guidelines, 2021: Diseases Characterized by Vulvovaginal Itching, Burning, Irritation, Odor or Discharge","https://www.cdc.gov/std/treatment-guidelines/vaginal-discharge.htm",{"sourceId":182,"title":183,"canonicalId":184,"canonicalUrl":185,"publisher":174,"sourceType":186,"publicationDate":187,"lastChecked":22},"cdc-candidiasis-testing-2024","Testing and Diagnosis for Candidiasis",null,"https://www.cdc.gov/candidiasis/testing/index.html","regulator","2024-04-24",{"sourceId":189,"title":190,"canonicalId":191,"canonicalUrl":192,"publisher":193,"sourceType":175,"publicationDate":194,"lastChecked":22},"issvd-vaginitis-recommendations-2023","International Society for the Study of Vulvovaginal Disease Recommendations for the Diagnosis and Treatment of Vaginitis","doi:10.59153/adm.rdtv.001","https://www.issvd.org/resources/recommendations-for-the-diagnosis-and-treatment-of-vaginitis","International Society for the Study of Vulvovaginal Disease","2023-03-01",{"sourceId":196,"title":197,"canonicalId":198,"canonicalUrl":199,"publisher":200,"sourceType":201,"publicationDate":202,"lastChecked":22},"owh-vaginal-yeast-infections-2025","Vaginal yeast infections","Office on Women's Health health topic: vaginal yeast infections","https://womenshealth.gov/a-z-topics/vaginal-yeast-infections","Office on Women's Health, U.S. Department of Health and Human Services","official-care-service","2025-10-24",[204,219,230,241,264,274,286,297,306],{"claimId":205,"exactClaim":206,"outcome":207,"population":208,"verdict":209,"evidenceLevel":210,"rationale":211,"safetyStatus":212,"evidenceAsOf":22,"lastUpdated":22,"status":213,"changeHistory":214,"sources":215},"vaginal-symptoms-do-not-identify-vvc","Itching, soreness, burning, external dysuria, pain during sex, redness, swelling, and abnormal discharge can occur with vulvovaginal candidiasis, but no one of these symptoms is specific enough to identify candidiasis as the cause.","accurate distinction of vulvovaginal candidiasis from other causes of vulvovaginal symptoms","adolescents and adults with current vulvovaginal symptoms, including people who self-attribute the symptoms to yeast","supported","strong","CDC and ISSVD guideline syntheses agree that candidiasis symptoms overlap with other vaginal and vulvar conditions and cannot establish etiology by themselves.","usual-cautions","active",[],[216,217,218],{"title":171,"canonicalId":172,"canonicalUrl":173,"publisher":174,"sourceType":175,"publicationDate":176,"lastChecked":22},{"title":179,"canonicalId":172,"canonicalUrl":180,"publisher":174,"sourceType":175,"publicationDate":176,"lastChecked":22},{"title":190,"canonicalId":191,"canonicalUrl":192,"publisher":193,"sourceType":175,"publicationDate":194,"lastChecked":22},{"claimId":220,"exactClaim":221,"outcome":222,"population":223,"verdict":209,"evidenceLevel":210,"rationale":224,"safetyStatus":212,"evidenceAsOf":22,"lastUpdated":22,"status":213,"changeHistory":225,"sources":226},"first-episode-vaginal-symptoms-need-etiologic-evaluation","A first episode of unexplained vulvovaginal symptoms should be treated as an unresolved symptom presentation rather than as confirmed yeast solely from history or symptom pattern; history, examination, and appropriate testing are used to determine the cause.","correct etiologic classification before condition-specific management","adolescents and adults with a first recognized episode of vulvovaginal itching, burning, irritation, odor, pain, or discharge without an established diagnosis","The CDC vaginal-discharge guideline states that history alone is insufficient and warrants history, examination, and laboratory testing; the CDC candidiasis page and ISSVD recommendations support testing because symptom patterns overlap.",[],[227,228,229],{"title":179,"canonicalId":172,"canonicalUrl":180,"publisher":174,"sourceType":175,"publicationDate":176,"lastChecked":22},{"title":183,"canonicalId":184,"canonicalUrl":185,"publisher":174,"sourceType":186,"publicationDate":187,"lastChecked":22},{"title":190,"canonicalId":191,"canonicalUrl":192,"publisher":193,"sourceType":175,"publicationDate":194,"lastChecked":22},{"claimId":231,"exactClaim":232,"outcome":233,"population":234,"verdict":209,"evidenceLevel":210,"rationale":235,"safetyStatus":212,"evidenceAsOf":22,"lastUpdated":22,"status":213,"changeHistory":236,"sources":237},"candida-detection-alone-does-not-establish-vvc","Detecting Candida in a vaginal sample without compatible symptoms and signs does not by itself establish symptomatic vulvovaginal candidiasis because asymptomatic colonization occurs.","distinction between asymptomatic Candida colonization and symptomatic vulvovaginal candidiasis","adolescents and adults with Candida detected in a vaginal sample, including those with minimal, nonspecific, or absent symptoms","CDC diagnostic guidance and the ISSVD guideline explicitly distinguish Candida detection or positive culture from symptomatic infection and do not treat asymptomatic detection as proof of disease.",[],[238,239,240],{"title":171,"canonicalId":172,"canonicalUrl":173,"publisher":174,"sourceType":175,"publicationDate":176,"lastChecked":22},{"title":183,"canonicalId":184,"canonicalUrl":185,"publisher":174,"sourceType":186,"publicationDate":187,"lastChecked":22},{"title":190,"canonicalId":191,"canonicalUrl":192,"publisher":193,"sourceType":175,"publicationDate":194,"lastChecked":22},{"claimId":242,"exactClaim":243,"outcome":244,"population":245,"verdict":209,"evidenceLevel":210,"rationale":246,"safetyStatus":212,"evidenceAsOf":22,"lastUpdated":22,"status":213,"changeHistory":247,"sources":248},"rvvc-recurrence-definition","Current CDC and ISSVD guidance generally defines recurrent vulvovaginal candidiasis as three or more symptomatic episodes within one year, but older guidance and studies often use four or more; reaching an episode-count threshold does not replace microbiologic confirmation.","classification of a symptom history as possible recurrent vulvovaginal candidiasis without conflating episode count with confirmed diagnosis","adolescents and adults reporting repeated vulvovaginal symptoms or repeated presumed yeast episodes over 12 months","CDC and ISSVD use a three-or-more symptomatic-episode threshold while the reviewed quality-of-life cohorts use four-or-more definitions. Both guidelines require diagnostic evidence for recurrent or complicated presentations, so the threshold is an orientation category rather than proof that every episode was candidiasis.",[],[249,250,251,258],{"title":171,"canonicalId":172,"canonicalUrl":173,"publisher":174,"sourceType":175,"publicationDate":176,"lastChecked":22},{"title":190,"canonicalId":191,"canonicalUrl":192,"publisher":193,"sourceType":175,"publicationDate":194,"lastChecked":22},{"title":252,"canonicalId":253,"canonicalUrl":254,"publisher":255,"sourceType":256,"publicationDate":257,"lastChecked":22},"Subjective health status and health-related quality of life among women with recurrent vulvovaginal candidosis in Europe and the USA","doi:10.1186/1477-7525-11-169","https://pubmed.ncbi.nlm.nih.gov/24119427/","Health and Quality of Life Outcomes","observational-study","2013-10-11",{"title":259,"canonicalId":260,"canonicalUrl":261,"publisher":262,"sourceType":256,"publicationDate":263,"lastChecked":22},"Influence of recurrent vulvovaginal candidiasis on quality of life issues","doi:10.1007/s00404-019-05228-3","https://pubmed.ncbi.nlm.nih.gov/31270690/","Archives of Gynecology and Obstetrics","2019-07-03",{"claimId":265,"exactClaim":266,"outcome":267,"population":268,"verdict":209,"evidenceLevel":210,"rationale":269,"safetyStatus":212,"evidenceAsOf":22,"lastUpdated":22,"status":213,"changeHistory":270,"sources":271},"recurrent-vvc-requires-microbiologic-confirmation","Before labeling repeated vulvovaginal symptoms as recurrent vulvovaginal candidiasis or starting a recurrence-management plan, microbiologic confirmation is needed; culture also identifies the Candida species and supports susceptibility assessment when symptoms persist.","confirmation and species-level classification of recurrent or treatment-persistent vulvovaginal candidiasis","adolescents and adults with repeated suspected yeast episodes, complicated vulvovaginal candidiasis, or symptoms persisting despite antifungal treatment","ISSVD makes positive yeast culture crucial before a recurrent-candidiasis plan and calls culture the confirmation standard; CDC recommends culture or PCR for complicated VVC and consideration of susceptibility testing when symptoms persist.",[],[272,273],{"title":171,"canonicalId":172,"canonicalUrl":173,"publisher":174,"sourceType":175,"publicationDate":176,"lastChecked":22},{"title":190,"canonicalId":191,"canonicalUrl":192,"publisher":193,"sourceType":175,"publicationDate":194,"lastChecked":22},{"claimId":275,"exactClaim":276,"outcome":277,"population":278,"verdict":209,"evidenceLevel":279,"rationale":280,"safetyStatus":212,"evidenceAsOf":22,"lastUpdated":22,"status":213,"changeHistory":281,"sources":282},"persistent-returned-vaginal-symptoms-require-reassessment","No improvement, only partial improvement, symptom return after treatment, worsening, or new vulvovaginal symptoms do not confirm residual yeast; they change the situation to unresolved symptoms that require reassessment of the diagnosis and appropriate testing.","recognition of treatment nonresponse or recurrence as diagnostic reassessment states rather than proof of ongoing candidiasis","adolescents and adults with suspected or previously diagnosed vulvovaginal candidiasis whose symptoms do not fully resolve, return, worsen, or change after treatment","moderate","CDC requires clinical evaluation and testing for persistent symptoms after over-the-counter treatment or recurrence within two months and follow-up for persistent or recurrent symptoms. ISSVD emphasizes culture and exclusion of other causes in complicated or persistent presentations. The exact urgency attached to worsening or new observable symptoms remains locale-safety owned.",[],[283,284,285],{"title":171,"canonicalId":172,"canonicalUrl":173,"publisher":174,"sourceType":175,"publicationDate":176,"lastChecked":22},{"title":179,"canonicalId":172,"canonicalUrl":180,"publisher":174,"sourceType":175,"publicationDate":176,"lastChecked":22},{"title":190,"canonicalId":191,"canonicalUrl":192,"publisher":193,"sourceType":175,"publicationDate":194,"lastChecked":22},{"claimId":287,"exactClaim":288,"outcome":289,"population":290,"verdict":209,"evidenceLevel":210,"rationale":291,"safetyStatus":212,"evidenceAsOf":22,"lastUpdated":22,"status":213,"changeHistory":292,"sources":293},"failed-vvc-treatment-broadens-differential","When presumed yeast treatment does not resolve symptoms, the differential should be reopened to include bacterial vaginosis, trichomoniasis, cervicitis, mixed vaginitis, non-albicans Candida, and mechanical, chemical, allergic, inflammatory, vulvar, or pain conditions rather than simply repeating the yeast label.","identification of an alternative or coexisting cause after failed empiric vulvovaginal-candidiasis treatment","adolescents and adults with persistent, recurrent, or changed vulvovaginal symptoms after empiric or diagnosis-directed antifungal treatment","CDC identifies BV, trichomoniasis, cervicitis, and noninfectious mechanical, chemical, and allergic causes in the differential and recommends specialist consideration when symptoms remain unexplained. ISSVD additionally addresses mixed vaginitis, inflammatory vaginitis, vulvodynia, vulvar dermatoses, and non-albicans yeast in persistent presentations.",[],[294,295,296],{"title":179,"canonicalId":172,"canonicalUrl":180,"publisher":174,"sourceType":175,"publicationDate":176,"lastChecked":22},{"title":171,"canonicalId":172,"canonicalUrl":173,"publisher":174,"sourceType":175,"publicationDate":176,"lastChecked":22},{"title":190,"canonicalId":191,"canonicalUrl":192,"publisher":193,"sourceType":175,"publicationDate":194,"lastChecked":22},{"claimId":298,"exactClaim":299,"outcome":300,"population":301,"verdict":209,"evidenceLevel":210,"rationale":302,"safetyStatus":212,"evidenceAsOf":22,"lastUpdated":22,"status":213,"changeHistory":303,"sources":304},"uncomplicated-vvc-expected-course","For confirmed uncomplicated vulvovaginal candidiasis treated with a recommended azole regimen, symptom relief and a negative culture occur in about 80% to 90% of patients who complete treatment; routine follow-up is generally unnecessary only when symptoms resolve.","symptom relief and mycologic clearance after completed treatment, with recognition of persistence as outside the usual course","nonpregnant, nonimmunocompromised adolescents and adults with confirmed mild-to-moderate uncomplicated vulvovaginal candidiasis treated with a recommended azole regimen","The current CDC guideline synthesis reports symptom relief and negative cultures in 80% to 90% of treatment completers and separates resolved uncomplicated episodes from persistent or recurrent symptoms that need follow-up. Comparative regimen conclusions remain owned by the Pathway A treatment pack.",[],[305],{"title":171,"canonicalId":172,"canonicalUrl":173,"publisher":174,"sourceType":175,"publicationDate":176,"lastChecked":22},{"claimId":307,"exactClaim":308,"outcome":309,"population":310,"verdict":209,"evidenceLevel":279,"rationale":311,"safetyStatus":212,"evidenceAsOf":22,"lastUpdated":22,"status":213,"changeHistory":312,"sources":313},"structured-vaginal-history-supports-evaluation","Recording symptom timing and pattern, episode count, menstrual context, relevant exposures, prior test results, treatments used, adherence, adverse effects, and response supports evaluation of recurrent or unresolved vulvovaginal symptoms, but the history cannot establish the cause without appropriate examination and testing.","completeness and interpretability of clinical evaluation for recurrence or treatment failure","adolescents and adults preparing for evaluation of recurrent, persistent, or previously treated vulvovaginal symptoms","CDC specifies the history elements relevant to vaginal symptoms while warning that history alone is diagnostically insufficient. ISSVD ties recurrence decisions to episode pattern, testing, species, and treatment response; a 2026 qualitative study describes documentation, test access, and interpretation as parts of the diagnostic pathway but cannot by itself establish outcome benefit from a tool.",[],[314,315,316],{"title":179,"canonicalId":172,"canonicalUrl":180,"publisher":174,"sourceType":175,"publicationDate":176,"lastChecked":22},{"title":190,"canonicalId":191,"canonicalUrl":192,"publisher":193,"sourceType":175,"publicationDate":194,"lastChecked":22},{"title":317,"canonicalId":318,"canonicalUrl":319,"publisher":320,"sourceType":256,"publicationDate":321,"lastChecked":22},"It's not just thrush, it's recurrent thrush: a qualitative study of patient and clinician perspectives on diagnosing recurrent vulvovaginal candidiasis","doi:10.3399/BJGP.2025.0437","https://pubmed.ncbi.nlm.nih.gov/41628983/","British Journal of General Practice","2026-06-01",[323,336,357],{"safetyId":324,"observableTrigger":325,"careTier":326,"action":327,"applicablePopulations":328,"excludedPopulations":330,"locale":6,"checkedAt":22,"expiresAt":332,"sources":333},"us-vvc-persistent-or-early-return-routine","Vaginal symptoms persist after an over-the-counter yeast treatment, return less than 2 months after treatment, or continue or recur after prescribed treatment.","routine","Arrange a clinician visit for evaluation and testing instead of repeating self-treatment without reassessment.",[329],"adolescents and adults in the United States with vaginal or vulvar symptoms after yeast treatment",[331],"people with a simultaneous medical emergency or acute mental-health crisis, who need the applicable emergency route","2027-01-15",[334,335],{"title":171,"canonicalId":172,"canonicalUrl":173,"publisher":174,"sourceType":175,"publicationDate":176,"lastChecked":22},{"title":197,"canonicalId":198,"canonicalUrl":199,"publisher":200,"sourceType":201,"publicationDate":202,"lastChecked":22},{"safetyId":337,"observableTrigger":338,"careTier":326,"action":339,"applicablePopulations":340,"excludedPopulations":343,"locale":6,"checkedAt":22,"expiresAt":346,"sources":347},"us-vvc-pregnancy-treatment-routine","The person is pregnant, might be pregnant, or becomes pregnant while considering or taking treatment for vaginal yeast symptoms.","Contact the pregnancy-care clinician before self-treating; do not use the exact fluconazole products in DailyMed setid 737e0fac-a2d2-4053-a0d7-edbfb6248f69 unless the clinician directs their use, and report pregnancy during use promptly.",[341,342],"pregnant or possibly pregnant people in the United States with vaginal yeast symptoms","people who become pregnant while taking the exact referenced fluconazole tablet or suspension products",[344,345],"nonpregnant people not planning pregnancy","users of other products whose labels were not checked by this record","2026-10-15",[348,349,356],{"title":171,"canonicalId":172,"canonicalUrl":173,"publisher":174,"sourceType":175,"publicationDate":176,"lastChecked":22},{"title":350,"canonicalId":351,"canonicalUrl":352,"publisher":353,"sourceType":354,"publicationDate":355,"lastChecked":22},"FLUCONAZOLE tablet; FLUCONAZOLE powder, for suspension","DailyMed setid 737e0fac-a2d2-4053-a0d7-edbfb6248f69","https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=737e0fac-a2d2-4053-a0d7-edbfb6248f69","U.S. National Library of Medicine DailyMed; labeler Greenstone LLC","official-product","2026-04-02",{"title":197,"canonicalId":198,"canonicalUrl":199,"publisher":200,"sourceType":201,"publicationDate":202,"lastChecked":22},{"safetyId":358,"observableTrigger":359,"careTier":326,"action":360,"applicablePopulations":361,"excludedPopulations":363,"locale":6,"checkedAt":22,"expiresAt":332,"sources":366},"us-vvc-compromised-host-routine","The person with vaginal yeast symptoms has poorly controlled diabetes, HIV or another immunocompromising condition, an underlying immunodeficiency, or current corticosteroid or other immunosuppressive therapy.","Arrange clinician evaluation rather than relying on a short course of self-treatment, because diagnosis and response may differ in these populations.",[362],"adolescents and adults in the United States with vaginal yeast symptoms and a listed condition or therapy",[364,365],"people without a listed condition or therapy","people with a simultaneous medical emergency, who need emergency care",[367,368],{"title":171,"canonicalId":172,"canonicalUrl":173,"publisher":174,"sourceType":175,"publicationDate":176,"lastChecked":22},{"title":197,"canonicalId":198,"canonicalUrl":199,"publisher":200,"sourceType":201,"publicationDate":202,"lastChecked":22},[370,373,376],{"rel":371,"hreflang":6,"href":372},"alternate","https://candipedia.org/en/symptoms-conditions/vaginal-yeast-infection/",{"rel":371,"hreflang":374,"href":375},"pl-PL","https://candipedia.org/pl/objawy-i-problemy/grzybica-pochwy/",{"rel":371,"hreflang":377,"href":372},"x-default",1784685064868]